Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus
            NPH Insulin during Pregnancy

<table class="table-group" width="800px"><tr class="fig-image" id="a"><td><img alt="649070.fig.002a" src="https://static.hindawi.com/articles/ogi/volume-2012/649070/figures/649070.fig.002a.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(a) </b>1st Trimester HbA<sub>1c</sub></td></tr></table></td></tr><tr class="fig-image" id="b"><td><img alt="649070.fig.002b" src="https://static.hindawi.com/articles/ogi/volume-2012/649070/figures/649070.fig.002b.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(b) </b>Severe hypoglycemia</td></tr></table></td></tr><tr class="fig-image" id="c"><td><img alt="649070.fig.002c" src="https://static.hindawi.com/articles/ogi/volume-2012/649070/figures/649070.fig.002c.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(c) </b>Preeclampsia</td></tr></table></td></tr><tr class="fig-image" id="d"><td><img alt="649070.fig.002d" src="https://static.hindawi.com/articles/ogi/volume-2012/649070/figures/649070.fig.002d.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(d) </b>Gestational/new-onset hypertension</td></tr></table></td></tr></table>

<table>Meta-analysis results for maternal outcomes.</table>

Obstetrics and Gynecology International

fig2

Figure 2

Figure 2: Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus
            NPH Insulin during Pregnancy 

Figure 2 | Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus
            NPH Insulin during Pregnancy 

Obstetrics and Gynecology International

Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus NPH Insulin during Pregnancy

Figure 2